The short-term outlook is bullish for the stock of Glenmark Pharmaceuticals. There is a resistance near current levels at ₹553. But the price action on the chart leaves the chances high for the stock to breach this hurdle. Such a break will boost the bullish momentum and can trigger a strong follow-through buying. In that case, Glenmark Pharmaceuticals share price can go up to ₹490 over the next two-three weeks.
Immediate support is at ₹440 which is likely to limit the downside in the near-term. Traders can go long. Accumulate on dips at ₹442. Stop-loss can be kept at ₹431. Trail the stop-loss up to ₹455 as soon as the stock moves up to ₹464. Move the stop-loss further up to ₹473 when the share price touches ₹478. Exit the long positions at ₹485.
(Note: The recommendations are based on technical analysis. There is risk of loss in trading.)
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.